✕ CLOSE Online Special City News Entrepreneurship Environment Factcheck Everything Woman Home Front Islamic Forum Life Xtra Property Travel & Leisure Viewpoint Vox Pop Women In Business Art and Ideas Bookshelf Labour Law Letters
Click Here To Listen To Trust Radio Live

Firms team up to ease cancer care for Nigerians

Me Cure Healthcare Ltd, a leading diagnostic and healthcare company that specializes in cancer management, diagnostic services, among others has partnered with Quickraiz, a donation-based…

Me Cure Healthcare Ltd, a leading diagnostic and healthcare company that specializes in cancer management, diagnostic services, among others has partnered with Quickraiz, a donation-based crowdfunding platform owned by Ativo Nigeria Limited, to provide accessible funding and treatment to cancer patients in need of PET/CT treatment in Nigeria.

 With this partnership, patients seeking cancer treatment and management at Me Cure’s PET/CT Centre in Lagos who cannot afford it would be provided with alternative financing options, one of which is a crowdfunding drive on the Quickraiz platform to raise funds for their care at a discounted rate.

 It would be recalled that MeCure recently launched their Tomography and Computed Tomography (PET/CT) Centre in Lagos, the first PET/CT Centre in West Africa with Discovery IQ 3-Ring imaging technology for accurate diagnosis and to enhance cancer treatment for patients.

The Chief Strategist for MeCure Healthcare, Dr Kunle Megbuwawon, said, “We set up the PET/CT Centre to ensure that cancer can properly be staged, with precise location and metastasis determined for appropriate treatment protocol as well as the progress of care determined to an enhanced significant increase in survival rate.

 The Chief Growth Officer of Ativo Ltd, Nene Obichie, noted that Quickraiz “is redefining the landscape of fundraising in Nigeria.”  – Mail Online

VERIFIED: It is now possible to live in Nigeria and earn salary in US Dollars with premium domains, you can earn as much as $12,000 (₦18 Million).
Click here to start.